DNA2 inhibitor C5 is a potent, competitive, and specific inhibitor of the DNA2 nuclease. It has an IC50 of 20 μM and effectively inhibits the nuclease, DNA-dependent ATPase, helicase, and DNA-binding activities of DNA2. This compound is suitable for use in breast cancer and colorectal cancer research.
- Potent, competitive, and specific DNA2 nuclease inhibitor.
- IC50 of 20 μM against DNA2 nuclease.
- Inhibits multiple activities of DNA2, including nuclease, DNA-dependent ATPase, helicase, and DNA-binding.
- Applicable in breast cancer and colorectal cancer research.
- Solid appearance, light yellow to yellow in color.